Oral Health, Microbial Burden and COVID-19
ORACLE
2 other identifiers
observational
150
1 country
1
Brief Summary
An observational study of patients with COVID-19 confirmed cases (with various degrees of severity) and controls. Oral and nasal swabs will be taken from 150 patients (50 with mild form and 50 with severe form of COVID-19 with or without mechanical ventilation, 50 healthy controls).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2020
CompletedStudy Start
First participant enrolled
December 13, 2020
CompletedFirst Posted
Study publicly available on registry
December 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2021
CompletedFebruary 4, 2021
February 1, 2021
12 months
December 11, 2020
February 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oral microbial signature
To assess the oral microbial signatures that relates to SARS-CoV2 in patients with no, mild and severe disease.
Day 1
Secondary Outcomes (1)
Nasal microbial signature
Day 1
Study Arms (3)
Controls tested PCR (-) for COVID-19
Tested PCR (+) for COVID-19, Mild - not admitted to the hospital
Tested PCR (+) for COVID-19, Severe - admitted to ICU (Intensive Care Unit)
Interventions
PCR test for SARS-CoV2, oral and nasal swab
Eligibility Criteria
Adults who tested (PCR) positive or negative for SARS-CoV2 infection
You may qualify if:
- Must provide written informed consent
- Subjects have to be tested (PCR) positive or negative for SARS-CoV2 infection
- Must be able to provide oral and nasal swabbing within 48 hours of polymerise chain reaction (PCR) test results
You may not qualify if:
- a. Under the age of 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eastman Dental Insitute and Hospitallead
- DermBiont, Inc.collaborator
- University College London Hospitalscollaborator
- The Whittington Hospital NHS Trustcollaborator
Study Sites (1)
University College Hospital (UCH), UCL Eastman Dental Institute
London, United Kingdom
Biospecimen
Oral and nasal swab
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 11, 2020
First Posted
December 16, 2020
Study Start
December 13, 2020
Primary Completion
December 12, 2021
Study Completion
December 12, 2021
Last Updated
February 4, 2021
Record last verified: 2021-02